🇺🇸 FDA
Patent

US 8652516

Doxycycline formulations, and methods of treating rosacea

granted A61KA61K31/65A61K9/0053

Quick answer

US patent 8652516 (Doxycycline formulations, and methods of treating rosacea) held by Cerovene, Inc. expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cerovene, Inc.
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/65, A61K9/0053, A61K9/4808, A61K9/4825